ConductScience.org, home
The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.
API referenceFor AI assistants

Trial · NCT06930118

Papers35

The papers the trial lists on ClinicalTrials.gov.

1 to 20 of 35

Download this page as JSON
PMIDListed asSource
19111391RESULTPubMed
21345145RESULTPubMed
23177514RESULTPubMed
25088940RESULTPubMed
25600568RESULTPubMed
25834402RESULTPubMed
25981818RESULTPubMed
26338525RESULTPubMed
27149842RESULTPubMed
27629931RESULTPubMed
28694034RESULTPubMed
28698201RESULTPubMed
29215955RESULTPubMed
29284010RESULTPubMed
29555258RESULTPubMed
29946728RESULTPubMed
31044725RESULTPubMed
31262657RESULTPubMed
32343640RESULTPubMed
32379280RESULTPubMed

trials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06930118/papers

API referenceFor AI assistants